|
Real-time Estimate
Cboe BZX
14:06:54 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 94.06 USD | -3.19% |
|
-1.89% | +18.27% |
| 08-12 | JPMorgan Adjusts Price Target on CVS Health to $118 From $111, Keeps Overweight Rating | MT |
| 08-07 | DA Davidson Adjusts Price Target on CVS Health to $120 From $100, Maintains Buy Rating | MT |
| Market Cap | 124B 107B 101B 91.67B 172B 11,881B 175B 1,180B 462B 5,953B 467B 456B 19,801B | P/E 2026 * |
14.3x | P/E 2027 * | 13.7x |
|---|---|---|---|---|---|
| Enterprise Value | 176B 152B 143B 130B 244B 16,845B 248B 1,673B 655B 8,439B 661B 647B 28,073B | EV / Sales 2026 * |
0.42x | EV / Sales 2027 * | 0.4x |
| Free-Float |
71.17% | Yield 2026 * |
2.74% | Yield 2027 * | 2.82% |
Last Transcript: CVS Health Corporation
| 1 day | -3.23% | ||
| 1 week | -1.89% | ||
| Current month | -10.12% | ||
| 1 month | -12.66% | ||
| 3 months | -2.22% | ||
| 6 months | +20.03% | ||
| Current year | +18.27% |
| 1 week | 93.01 |  | 97.51 |
| 1 month | 93.01 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 69.4 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/14/26 | Free | Director | 1,737 | 0.0001% | ||
| 2/28/26 | Tax | Executive/Senior Manager | 7,886 | 0.0006% | ||
| 2/28/26 | Tax | Chief Executive Officer | 1,944 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.19% | -1.89% | +33.76% | +40.51% | 124B | |
| +0.31% | -1.93% | +3.15% | +52.87% | 87.61B | |
| -0.59% | +0.68% | +2.98% | +59.10% | 30.7B | |
| +0.85% | -0.67% | +31.91% | +78.50% | 25.87B | |
| -0.65% | +2.51% | +55.52% | +274.02% | 21.57B | |
| +0.17% | -0.56% | -9.06% | -12.23% | 21.5B | |
| -1.93% | -2.80% | -13.58% | +8.98% | 14.02B | |
| -0.61% | -3.59% | -4.61% | -9.68% | 12.59B | |
| -1.46% | -3.32% | +33.28% | +76.46% | 11.48B | |
| +15.38% | +15.16% | +152.10% | +2,172.73% | 10.29B | |
| Average | +0.73% | +0.92% | +28.54% | +274.12% | 35.99B | |
| Weighted average by Cap. | -0.83% | +0.24% | +22.48% | +117.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 418B 361B 338B 308B 579B 39,940B 587B 3,966B 1,554B 20,010B 1,568B 1,534B 66,562B | 430B 371B 348B 317B 596B 41,078B 604B 4,079B 1,598B 20,580B 1,613B 1,578B 68,459B |
| Net income | 8.8B 7.6B 7.13B 6.49B 12.2B 841B 12.37B 83.54B 32.74B 421B 33.03B 32.32B 1,402B | 9.1B 7.86B 7.37B 6.72B 12.63B 870B 12.8B 86.43B 33.87B 436B 34.18B 33.44B 1,451B |
| Net Debt | 51.92B 44.82B 42.05B 38.3B 72.01B 4,964B 73.01B 493B 193B 2,487B 195B 191B 8,272B | 49.15B 42.43B 39.8B 36.25B 68.17B 4,699B 69.11B 467B 183B 2,354B 185B 181B 7,831B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-17 | US$93.86 | -3.40% | 3,457,413 |
| 26-08-14 | US$97.16 | +2.28% | 9,439,256 |
| 26-08-13 | US$94.99 | +0.29% | 6,493,249 |
| 26-08-12 | US$94.72 | +1.30% | 8,257,543 |
| 26-08-11 | US$93.50 | -2.27% | 8,122,813 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
